皮层表面铁沉积与脑淀粉样血管病首次脑出血
本研究在236例无脑出血的 probable 脑淀粉样血管病(CAA)患者中,评估皮层表面铁沉积(cSS)与首次症状性脑叶出血的关系。中位随访3.26年,cSS是首次脑叶出血的独立预测因素(HR 4.04),5年出血风险在cSS阳性者中为19%,阴性者为6%。
要点
- cSS在无脑出血的 probable CAA 患者中患病率为34%。
- cSS阳性者5年首次症状性脑叶出血风险为19%,阴性者为6%。
- cSS是首次脑叶出血的独立预测因素,校正后HR为4.04。
核心结论
- cSS与CAA患者未来首次症状性脑叶出血风险增加独立相关(HR 4.04;95%CI 1.73-9.44,p=0.001)。
研究设计与样本
- 单中心队列分析连续纳入符合改良Boston标准 probable CAA 且无脑出血的患者236例,前瞻性随访首次症状性脑叶出血。
主要发现
- 中位随访3.26年(四分位距1.42-5.50年),27/236例(11.4%)发生首次症状性脑叶出血。
- cSS是首次脑出血时间的预测因素(p=0.0007,log-rank检验)。
- 5年随访时症状性出血风险:基线cSS阳性者19%(95%CI 11%-32%),cSS阴性者6%(95%CI 3%-12%)。
- 多变量Cox回归中,校正年龄、脑叶微出血负荷及白质高信号后,cSS是唯一独立预测因素(HR 4.04;95%CI 1.73-9.44,p=0.001)。
临床怎么用
- cSS可作为CAA患者未来脑叶出血风险分层指标,可能影响抗血栓药物使用等临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether cortical superficial siderosis (cSS) is associated with increased risk of future first-ever symptomatic lobar intracerebral hemorrhage (ICH) in patients with cerebral amyloid angiopathy (CAA) presenting with neurologic symptoms and without ICH. METHODS: Consecutive patients meeting modified Boston criteria for probable CAA in the absence of ICH from a single-center cohort were analyzed. cSS and other small vessel disease MRI markers were assessed according to recent consensus recommendations. Patients were followed prospectively for future incident symptomatic lobar ICH. Prespecified Cox proportional hazard models were used to investigate cSS and first-ever lobar ICH risk adjusting for potential confounders. RESULTS: The cohort included 236 patients with probable CAA without lobar ICH at baseline. cSS prevalence was 34%. During a median follow-up of 3.26 years (interquartile range 1.42-5.50 years), 27 of 236 patients (11.4%) experienced a first-ever symptomatic lobar ICH. cSS was a predictor of time until first ICH (p = 0.0007, log-rank test). The risk of symptomatic ICH at 5 years of follow-up was 19% (95% confidence interval [CI] 11%-32%) for patients with cSS at baseline vs 6% (95% CI 3%-12%) for patients without cSS. In multivariable Cox regression models, cSS presence was the only independent predictor of increased symptomatic ICH risk during follow-up (HR 4.04; 95% CI 1.73-9.44, p = 0.001), after adjusting for age, lobar cerebral microbleeds burden, and white matter hyperintensities. CONCLUSIONS: cSS is consistently associated with an increased risk of future lobar ICH in CAA with potentially important clinical implications for patient care decisions such as antithrombotic use.
引用
- Charidimou A, Boulouis G, Xiong L, et al. Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2017. PMID: 28356458. doi:10.1212/WNL.0000000000003866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。